BioPharma
Global Biopharma Market To Hit $566B By 2032 Amid...
The value of the global biopharmaceutical industry is expected to rise significantly, from $263 billion in 2022 to $566 billion by 2032, representing a compound...
BioPharma
Thermo Fisher Partners with X-ELIO for Renewable Energy
Thermo Fisher Scientific has taken a significant step toward achieving its sustainability goals by signing a 10-year virtual power purchase agreement (VPPA) with renewable energy...
BioPharma
Oncology Precision Medicine: Challenges and Opportunities for Biopharmaceutical Companies
With a growing shift towards tailored therapies for cancer treatment, personalized medicine emerges as a groundbreaking solution. Cancer has been a major cause of concern...
BioPharma
Transforming healthcare: 4D Lifetec’s revolutionary approach to early cancer...
In the rapidly advancing landscape of healthcare, 4D Lifetec emerges as a trailblazer, aiming to redefine the paradigm of early cancer detection. At the forefront...
BioPharma
2024 May Have Regulations Change In The Biopharma Backdrop
The scenario is that the regulators are all ramping up pressure when it comes to the biopharma industry in 2024. Pharma companies not only happen...
BioPharma
M&A Revival In The Biopharmaceutical Sector Back On Track
It is worth noting that the biopharmaceutical sector has gone on to experience a revival when it comes to mergers and acquisitions in the second...
BioPharma
Biopharma & Healthcare In Asia-Pacific – Leveraging Ties
In the last five years, there have been various local governments in the Asia-Pacific region that have enacted beneficial policies and also regulatory frameworks to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.